Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2000
12/05/2000US6156303 Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
12/05/2000US6156301 Genetric engineered interleukin
12/05/2000US6156300 Point mutants of N∇2 CSF-1 and carboxy truncated fragments thereof
12/05/2000CA2199843C Novel pka-binding proteins and uses thereof
12/05/2000CA2146150C Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof
12/05/2000CA2098921C Angiogenic peptides
12/05/2000CA2000596C Chromogenic merocyanine enzyme substrates
12/05/2000CA1341150C Amplifying the expression of recombinant dna products
12/05/2000CA1341149C Insulin receptor
11/2000
11/30/2000WO2000072023A2 Diagnosis and treatment of atherosclerosis and coronary heart disease
11/30/2000WO2000072021A2 Cancer associated antigens and uses therefor
11/30/2000WO2000072015A2 Diagnostics and therapeutics for cardiovascular disorders
11/30/2000WO2000072010A1 Use of an antibody to detect basophiles and/or mast cells
11/30/2000WO2000072008A2 Identification of novel mechanisms of drug resistance
11/30/2000WO2000071752A2 Assay for the detection of paclitaxel resistant cells in human tumors
11/30/2000WO2000071751A1 Diabetes gene
11/30/2000WO2000071748A2 Ers-genes, method of screening for chemical compounds capable of inducing ers in plants
11/30/2000WO2000071741A2 Dna encoding a human subunit of the 5-ht3 serotonin receptor
11/30/2000WO2000071737A2 Improved retroviral production by inhibition of the enveloppe cell receptor
11/30/2000WO2000071731A1 Phage-dependent super-production of biologically active protein and peptides
11/30/2000WO2000071726A1 Methods to inhibit infectious agent transmission during xenotransplantation
11/30/2000WO2000071725A2 Combination neisserial compositions
11/30/2000WO2000071724A2 Novel compounds from moraxella catarrhalis
11/30/2000WO2000071723A2 Methods for regulating protein conformation using molecular chaperones
11/30/2000WO2000071722A1 Novel genes to control flowering, transgenic plants, and uses thereof
11/30/2000WO2000071721A1 Novel gene regulating ethylene synthesis
11/30/2000WO2000071720A1 Il-1 eta dna and polypeptides
11/30/2000WO2000071719A1 Interleukin-1 hy2 materials and methods
11/30/2000WO2000071718A1 Gene therapy of pulmonary disease
11/30/2000WO2000071717A1 Secreted alpha-helical protein - 32
11/30/2000WO2000071716A2 Vascular endothelial growth factor dimers
11/30/2000WO2000071715A1 Fibroblast growth factor 11
11/30/2000WO2000071714A2 Methods of reducing factor viii clearance and compositions therefor
11/30/2000WO2000071713A1 Vascular endothelial growth factor variants
11/30/2000WO2000071712A1 Dsif dominant negative variant
11/30/2000WO2000071711A2 Differentially expressed genes in prostate cancer
11/30/2000WO2000071710A2 Expression products of genes involved in diseases related to cholesterol metabolism
11/30/2000WO2000071709A1 Polypeptides, vesicular carriers of glutamate and gaba
11/30/2000WO2000071708A2 Use of ef-ts for treating smooth muscle cell hyperplasia
11/30/2000WO2000071707A1 A method for the diagnosis and treatment of cancer and agents useful therefor
11/30/2000WO2000071705A1 Novel psychrotrophic bacterium and dna probe for detecting the bacterium
11/30/2000WO2000071704A1 Promoter having specific activity to pistil tissue
11/30/2000WO2000071701A1 Method for generating split, non-transferable genes that are able to express an active protein product
11/30/2000WO2000071698A2 Mixture for neutralizing enzyme inhibitors
11/30/2000WO2000071697A1 Method for searching physiologically active substance
11/30/2000WO2000071696A1 Gene for regulating disease resistance in plants
11/30/2000WO2000071693A2 Method for selecting improved vectors
11/30/2000WO2000071678A1 Inducible packaging cell lines for lentivirus vectors
11/30/2000WO2000071671A2 New mutant genes in familial british dementia and familial danish dementia
11/30/2000WO2000071668A2 Method for identifying components involved in signal transduction pathways in higher plants
11/30/2000WO2000071584A1 Seven transmembrane receptor genes
11/30/2000WO2000071583A1 Murine interleukin-1 homologue, il-1h3
11/30/2000WO2000071582A1 Fibroblast growth factor 14
11/30/2000WO2000071581A1 Novel polypeptide
11/30/2000WO2000071580A1 Secretory protein library and method for producing the same
11/30/2000WO2000071579A2 Regulating organelle homeostasis in a cell factory
11/30/2000WO2000071578A2 New polypeptides and their use for the rescue of fusion defective virus or retrovirus glycoproteins
11/30/2000WO2000071577A1 Meth1 and meth2 polynucleotides and polypeptides
11/30/2000WO2000071576A2 Adenovirus vectors encoding brain natriuretic peptide
11/30/2000WO2000071575A1 Models of prion disease
11/30/2000WO2000071574A2 Antigenic neisserial peptides
11/30/2000WO2000071573A2 Immunogenic peptides derived from mage and the use thereof
11/30/2000WO2000071568A1 Staphylococcal ica operon
11/30/2000WO2000071567A2 Fibroblast growth factor 13
11/30/2000WO2000071566A2 Novel organic anion transport proteins
11/30/2000WO2000071565A2 Fluorescent protein indicators
11/30/2000WO2000071564A2 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
11/30/2000WO2000071561A1 Cd4-independent hiv envelope proteins as vaccines and therapeutics
11/30/2000WO2000071555A2 509rr
11/30/2000WO2000071161A1 Essential genes of yeast as targets for antifungal agents, herbicides, insecticides and anti-proliferative drugs
11/30/2000WO2000071158A1 Tagged epitope protein transposable element
11/30/2000WO2000071152A1 Fibroblast growth factor 10
11/30/2000WO2000071151A1 Liver function controlling agents
11/30/2000WO2000071150A1 Tumor necrosis factor receptor 5
11/30/2000WO2000071149A2 Therapeutic uses of bpi protein products in humans with otitis media with effusion
11/30/2000WO2000071141A1 Modified factor viii
11/30/2000WO2000071081A2 Methods of diagnosis and treatment of meniere disease
11/30/2000WO2000071080A2 Interaction of the cyclic-amp-specific phosphodiesterase pde4d5 with rack1
11/30/2000WO2000070944A1 Genetically defined animal models and genetic markers for estrogen-induced cancer
11/30/2000WO2000070932A1 Method for induction synthesis of heat stress proteins (hsp) & production from herbaceous plants
11/30/2000WO2000070931A1 Method for producing stress proteins from vegetable material and harvesting machine for implementing said method
11/30/2000WO2000050620A3 Human endokine alpha and methods of use
11/30/2000WO2000050607A3 Goodpasture antigen binding protein
11/30/2000WO2000050581A3 Isolation and characterization of a n. crassa silencing gene and uses thereof
11/30/2000WO2000047739A3 Autoantigens for the diagnostic of endometriosis
11/30/2000WO2000047738A3 Human and mouse trek-1 potassium channel protein and their use
11/30/2000WO2000047735A3 NON-HUMAN TRANSGENIC ANIMAL WHOSE GERM CELLS AND SOMATIC CELLS CONTAIN A KNOCKOUT MUTATION IN DNA ENCODING ORPHAN NUCLEAR RECEPTOR ERRalpha
11/30/2000WO2000047615A3 Proteins related to neuronal regeneration and uses thereof
11/30/2000WO2000047611A3 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
11/30/2000WO2000047610A3 Method for altering undesirable immune responses to polypeptides
11/30/2000WO2000046358A3 Arabidopsis thaliana derived frigida gene conferring late flowering
11/30/2000WO2000044900A3 Nucleic-acid binding proteins
11/30/2000WO2000044775A3 Identification of broadly reactive hla restricted t cell epitopes
11/30/2000WO2000044772A3 Human serum albumin
11/30/2000WO2000044404A3 Methods for inhibiting brain tumor growth by using selected integrin antagonists
11/30/2000WO2000043790A3 Compositions and methods for the diagnosis and treatment of tumor
11/30/2000WO2000043525A3 Metalloproteinase-disintegrin family members: svph dnas and polypeptides
11/30/2000WO2000043520A3 Materials and methods for producing geminivirus resistant plants
11/30/2000WO2000043494A3 Control of virus infection using replication associated proteins, compositions and methods of use
11/30/2000WO2000043332A3 Biopolymers comprising human immunodeficiency virus tat
1 ... 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 2107 ... 2916